Bangkok Life Assurance Public Company (BLA) Fair Value & Analysis
Financial Services · TH · Market cap 42.7B THB
Fair value as of: Jun 26, 2026
From 15 valuation models · updated 4 days ago
Fair value updated Jun 26, 2026 — revised from 48.40 THB to 48.00 THB (−0.8%) since Jun 24, 2026. Share price +8.3% over the past month.
Price vs Fair Value (12 months)
12‑month range 13.20 THB – 24.53 THB · fair‑value band 36.00 THB – 60.00 THB · the 24.00 THB price screens below the 48.00 THB fair value. As of Jun 26, 2026.
✦ Find undervalued quality stocks — 35,000+ analysed Find stocks →Analysis
Bangkok Life Assurance Public Company (BLA) currently trades at 24.00 THB, while our model-based Fair Value estimate is 48.00 THB — implying the stock looks roughly 100.0% undervalued today. We read business quality at 95/100 (high quality), in the Financial Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, Bangkok Life Assurance Public Company generated revenue of 18.1B THB at a net margin of 40.4%. Revenue declined 9.1% year over year. It earns a return on equity of 14.5%. The balance sheet holds a net cash position of 6.7B THB. Fundamentals as of Jun 26, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.
About the company
Bangkok Life Assurance Public Company Limited, together with its subsidiaries, provides life insurance services in Thailand. The company's life insurance products include protection, savings, education, pension, health, critical illness, total permanent disability, and accident plans products. It also provides group insurance; and general insurance products comprises personal and business all risks insurance products, including fire, motor, burglary, personal accident, accident and personal health, travel accident, cancer, golfer's indemnity, home multicover, medical malpractice liability, business interruption, marine, hull, workmen's compensation, money, contractors' plant and equipment, contractors' all risks, erection all risks, boiler and pressure vessel, electronic equipment, industrial all risks, public liability, neon-sign, plate glass, fidelity guarantee, group accident and health, and shop multicover insurance products. In addition, the company offers bancassurance product…
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Bangkok Life Assurance Public Company reported revenue of 27.2B THB in FY2025 versus 47.6B THB in FY2021, a compound −13.1%/yr. Reported net income was 7.0B THB in FY2025, compounding +21.5%/yr from FY2021.
Open the full interactive analysis →
Similar stocks
6 more Insurance - Life stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Ping An Insurance (Group) Company 601318 | ¥53.48 | ¥106.96 | +100% |
| China Life Insurance Company 601628 | ¥32.82 | ¥65.64 | +100% |
| AIA Group AAGIY | $37.91 | $30.44 | -20% |
| Manulife Financial Corporation MFC | $40.34 | $76.10 | +89% |
| China Pacific Insurance (Group) Co CHPXF | $3.65 | $5.65 | +55% |
| Aflac Incorporated AFL | $117.75 | $93.12 | -21% |
Explore undervalued stocks
More undervalued Financial Services stocks →
Frequently asked questions
Is Bangkok Life Assurance Public Company (BLA) undervalued?
What is the fair value of BLA?
What is the quality score of BLA?
What is the revenue of Bangkok Life Assurance Public Company (BLA)?
What is the net profit margin of BLA?
Does Bangkok Life Assurance Public Company pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.